Association between Osteoprotegerin gene polymorphisms and risk of coronary artery disease: A systematic review and meta-analysis
Osteoprotegerin (OPG) has been demonstrated to be a novel biomarker for predicting prevalence and severity of coronary artery disease (CAD). Furthermore, recent studies have shown that OPG gene polymorphisms are associated with a susceptibility to CAD. However, published studies showed inconsistent...
Main Authors: | Jia P, Wu N, Jia D, Sun Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-12-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1515/bjmg-2017-0021 |
Similar Items
-
Role of osteoprotegerin rs3102735 gene polymorphism in acute ischemic stroke patients
by: Dina Monir, et al.
Published: (2023-04-01) -
Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran
by: Mohammad Hashemi, et al.
Published: (2014-12-01) -
Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
by: Teng Ma, et al.
Published: (2023-06-01) -
Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
by: Filip Przerwa, et al.
Published: (2023-12-01) -
Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis
by: Xu Han, et al.
Published: (2022-11-01)